181 related articles for article (PubMed ID: 9182886)
1. A cross-reactive idiotype in scleroderma.
Vázquez-Abad D; Tian L; Zanetti M; Rothfield NF
Clin Exp Immunol; 1997 Jun; 108(3):420-7. PubMed ID: 9182886
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal study of anticentromere and antitopoisomerase-I isotypes.
Vázquez-Abad D; Russell CA; Cusick SM; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1995 Mar; 74(3):257-70. PubMed ID: 7859416
[TBL] [Abstract][Full Text] [Related]
3. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
4. Idiotypic analysis of human anti-topoisomerase I autoantibodies.
Hildebrandt S; Noell GS; Vazquez-Abad D; Earnshaw WC; Zanetti M; Rothfield NF
Autoimmunity; 1991; 10(1):41-8. PubMed ID: 1660312
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies.
Jabs EW; Tuck-Muller CM; Anhalt GJ; Earnshaw W; Wise RA; Wigley F
Cytogenet Cell Genet; 1993; 63(3):169-75. PubMed ID: 8387418
[TBL] [Abstract][Full Text] [Related]
6. Idiotypic analysis of human anticentromere autoantibodies.
Hildebrandt S; Weiner ES; Earnshaw WC; Zanetti M; Rothfield NF
Autoimmunity; 1991; 9(2):131-40. PubMed ID: 1657226
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody detection in scleroderma patients. Diagnostic and analytical performances of a new coupled particle light scattering immunoassay.
Bizzaro N; Bonelli F; Tonutti E; Villalta D; Tozzolis R
Clin Exp Rheumatol; 2002; 20(1):45-51. PubMed ID: 11892707
[TBL] [Abstract][Full Text] [Related]
8. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
9. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
10. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in systemic sclerosis.
Vázquez-Abad D; Rothfield NF
Int Rev Immunol; 1995; 12(2-4):145-57. PubMed ID: 7650418
[TBL] [Abstract][Full Text] [Related]
12. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
[TBL] [Abstract][Full Text] [Related]
13. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies.
Akbarali Y; Matousek-Ronck J; Hunt L; Staudt L; Reichlin M; Guthridge JM; James JA
J Autoimmun; 2006 Dec; 27(4):272-80. PubMed ID: 17210244
[TBL] [Abstract][Full Text] [Related]
14. CRI-EM is a human idiotype highly specific for scleroderma.
Vázquez-Abad D; Tian L; Monteón V; Zanetti M; Rothfield NF
Ann N Y Acad Sci; 1997 Apr; 815():512-5. PubMed ID: 9186713
[No Abstract] [Full Text] [Related]
15. Frequency of autoantibodies to a major epitope on the carboxyl terminal fragment of CENP-B in patients with autoimmune disease.
Whyte J; Soriano E; Earnshaw WC; McHugh NJ
Br J Rheumatol; 1995 May; 34(5):407-12. PubMed ID: 7788167
[TBL] [Abstract][Full Text] [Related]
16. Identification of human anti-DNA, anti-RNP, anti-SM, and anti-SS-A serum antibodies bearing the cross-reactive 16/6 idiotype.
Kaburaki J; Stollar BD
J Immunol; 1987 Jul; 139(2):385-92. PubMed ID: 3298427
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis.
Perosa F; Favoino E; Cuomo G; Digiglio L; Dammacco F; Prete M; Valentini G; Racanelli V
Arthritis Res Ther; 2013 Jul; 15(4):R72. PubMed ID: 23837651
[TBL] [Abstract][Full Text] [Related]
18. Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
Mahler M; Maes L; Blockmans D; Westhovens R; Bossuyt X; Riemekasten G; Schneider S; Hiepe F; Swart A; Gürtler I; Egerer K; Fooke M; Fritzler MJ
Arthritis Res Ther; 2010; 12(3):R99. PubMed ID: 20487535
[TBL] [Abstract][Full Text] [Related]
19. Analysis of human antitopoisomerase-I idiotypes.
Vazquez-Abad D; Pascual V; Zanetti M; Rothfield NF
J Clin Invest; 1993 Sep; 92(3):1302-13. PubMed ID: 8397223
[TBL] [Abstract][Full Text] [Related]
20. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC
Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
